Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

12 Health Care Stocks Moving In Monday's Intraday Session

Author: Benzinga Insights | April 01, 2024 12:31pm

Gainers

  • Sunshine Biopharma (NASDAQ:SBFM) stock rose 86.3% to $0.11 during Monday's regular session. The company's market cap stands at $11.2 million.
  • Xilio Therapeutics (NASDAQ:XLO) stock rose 25.93% to $1.36. The market value of their outstanding shares is at $37.4 million.
  • Akanda (NASDAQ:AKAN) shares moved upwards by 24.35% to $0.14. The company's market cap stands at $1.2 million.
  • Mesoblast (NASDAQ:MESO) shares moved upwards by 20.95% to $6.06. The company's market cap stands at $614.9 million.
  • Brainstorm Cell (NASDAQ:BCLI) shares increased by 18.29% to $0.67. The market value of their outstanding shares is at $32.7 million. The company's, Q4 earnings came out today.
  • Adagene (NASDAQ:ADAG) stock moved upwards by 18.21% to $3.31. The company's market cap stands at $146.0 million.

Losers

  • Eiger BioPharmaceuticals (NASDAQ:EIGR) stock fell 67.8% to $1.61 during Monday's regular session. The market value of their outstanding shares is at $2.3 million.
  • Disc Medicine (NASDAQ:IRON) stock fell 55.98% to $27.41. The company's market cap stands at $676.5 million.
  • AEON Biopharma (AMEX:AEON) shares decreased by 40.74% to $6.88. The market value of their outstanding shares is at $255.4 million. The company's, Q4 earnings came out yesterday.
  • Biora Therapeutics (NASDAQ:BIOR) stock decreased by 30.92% to $0.76. The company's market cap stands at $20.6 million. As per the press release, Q4 earnings came out 4 days ago.
  • Sharecare (NASDAQ:SHCR) stock declined by 29.44% to $0.54. The company's market cap stands at $191.4 million. As per the press release, Q4 earnings came out 2 days ago.
  • ENDRA Life Sciences (NASDAQ:NDRA) stock fell 28.71% to $0.41. The market value of their outstanding shares is at $4.5 million. The company's, Q4 earnings came out 2 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ADAG AEON AKAN BCLI BIOR EIGR IRON MESO NDRA SBFM SHCR XLO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist